Cellectis S.A [ALCLS] vs BNP Paribas Easy [BLUE] Detailed Stock Comparison
Cellectis S.A
Euronext
Loading...
BNP Paribas Easy
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Cellectis S.A wins in 8 metrics, BNP Paribas Easy wins in 4 metrics, with 0 ties. Cellectis S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cellectis S.A | BNP Paribas Easy | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.88 | 15.99 | Cellectis S.A |
| Price-to-Book Ratio | 2.45 | N/A | N/A |
| Debt-to-Equity Ratio | 40.92 | 2.22 | BNP Paribas Easy |
| PEG Ratio | -2.68 | N/A | N/A |
| EV/EBITDA | -6.27 | -23.23 | BNP Paribas Easy |
| Profit Margin (TTM) | -93.00% | -27.22% | BNP Paribas Easy |
| Operating Margin (TTM) | -52.69% | -156.86% | Cellectis S.A |
| Return on Equity | -48.02% | -96.39% | Cellectis S.A |
| Return on Assets (TTM) | -7.43% | -23.08% | Cellectis S.A |
| Free Cash Flow (TTM) | $19.15M | $-42.67M | Cellectis S.A |
| 1-Year Return | 28.80% | -2.63% | Cellectis S.A |
| Price-to-Sales Ratio (TTM) | 3.84 | 17.56 | Cellectis S.A |
| Enterprise Value | $179.84M | $558.28M | BNP Paribas Easy |
| EV/Revenue Ratio | 3.29 | 21.17 | Cellectis S.A |
| Gross Profit Margin (TTM) | 85.50% | N/A | N/A |
| Revenue per Share (TTM) | $1 | N/A | N/A |
| Earnings per Share (Diluted) | $-0.51 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cellectis S.A vs BNP Paribas Easy Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cellectis S.A | -2.47% | -4.82% | 74.26% | 70.50% | 56.95% | 37.79% |
| BNP Paribas Easy | -1.82% | -2.20% | -0.89% | 0.52% | -5.19% | -5.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cellectis S.A | 28.80% | -34.35% | -83.45% | -92.09% | -60.37% | -60.37% |
| BNP Paribas Easy | -2.63% | 1.50% | 49.76% | -36.61% | -27.05% | -27.05% |
Performance & Financial Health Analysis: Cellectis S.A vs BNP Paribas Easy
| Metric | ALCLS | BLUE |
|---|---|---|
| Market Information | ||
| Market Cap | €243.88M | €463.10M |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 788,434 | 438 |
| 90 Day Avg. Volume | 412,272 | 2,712 |
| Last Close | €2.37 | €15.53 |
| 52 Week Range | €1.01 - €3.19 | €13.83 - €16.93 |
| % from 52W High | -25.82% | -8.30% |
| All-Time High | €41.95 (Nov 02, 2015) | €40.48 (Jun 30, 2014) |
| % from All-Time High | -94.35% | -61.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.92% | N/A |
| Quarterly Earnings Growth | 1.07% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.93% | -0.27% |
| Operating Margin (TTM) | -0.53% | -1.57% |
| Return on Equity (TTM) | -0.48% | -0.96% |
| Debt to Equity (MRQ) | 40.92 | 2.22 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.98 | N/A |
| Cash per Share (MRQ) | €0.61 | N/A |
| Operating Cash Flow (TTM) | €-28,777,597 | €-47,377,000 |
| Levered Free Cash Flow (TTM) | €-24,538,865 | €-42,854,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Cellectis S.A vs BNP Paribas Easy
| Metric | ALCLS | BLUE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.88 | 15.99 |
| Forward P/E | -2.68 | N/A |
| PEG Ratio | -2.68 | N/A |
| Price to Sales (TTM) | 3.84 | 17.56 |
| Price to Book (MRQ) | 2.45 | N/A |
| Market Capitalization | ||
| Market Capitalization | €243.88M | €463.10M |
| Enterprise Value | €179.84M | €558.28M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.29 | 21.17 |
| Enterprise to EBITDA | -6.27 | -23.23 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | €0.98 | N/A |
Financial Statements Comparison: Cellectis S.A vs BNP Paribas Easy
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALCLS | BLUE |
|---|---|---|
| Revenue/Sales | €10.66M | N/A |
| Cost of Goods Sold | €2.02M | N/A |
| Gross Profit | €8.64M | N/A |
| Research & Development | €21.93M | N/A |
| Operating Income (EBIT) | €-14.18M | N/A |
| EBITDA | €-6.34M | N/A |
| Pre-Tax Income | €-18.13M | N/A |
| Income Tax | €0 | N/A |
| Net Income (Profit) | €-18.13M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALCLS | BLUE |
|---|---|---|
| Cash & Equivalents | €127.64M | €3.57M |
| Total Current Assets | €271.82M | €34.68M |
| Total Current Liabilities | €162.57M | €82.17M |
| Long-Term Debt | €78.87M | €37.83M |
| Total Shareholders Equity | €116.20M | €44.46M |
| Retained Earnings | €-347.69M | N/A |
| Property, Plant & Equipment | €93.92M | €17.97M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALCLS | BLUE |
|---|---|---|
| Operating Cash Flow | €-18.57M | N/A |
| Capital Expenditures | €-395,000 | N/A |
| Free Cash Flow | €-17.56M | N/A |
| Debt Repayment | €-3.94M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALCLS | BLUE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 788,434 | 438 |
| Average Daily Volume (90 Day) | 412,272 | 2,712 |
| Shares Outstanding | 72.09M | 29.16M |
| Float Shares | 53.18M | N/A |
| % Held by Insiders | 0.48% | N/A |
| % Held by Institutions | 0.19% | N/A |
Dividend Analysis & Yield Comparison: Cellectis S.A vs BNP Paribas Easy
| Metric | ALCLS | BLUE |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |